Achieve Life Sciences, Inc. Proceeds from Maturities, Prepayments and Calls of Short-term Investments
Achieve Life Sciences, Inc. (ACHV) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of $10.23 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-07-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2017-07-31
- Achieve Life Sciences, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2017-06-30 was $759.00K, a 74.69% decline year-over-year.
- Achieve Life Sciences, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2017-03-31 was $9.47M, a 46.95% decline year-over-year.
- Achieve Life Sciences, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2016-12-31 was $12.80M, a 220.00% increase year-over-year.
- Achieve Life Sciences, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2016-09-30 was $13.50M, a 39.94% increase year-over-year.
- Achieve Life Sciences, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2016 was $47.16M, a 117.73% increase from fiscal 2015.
- Achieve Life Sciences, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2015 was $21.66M, a 13.00% decline from fiscal 2014.
- Achieve Life Sciences, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2014 was $24.89M, a 60.72% decline from fiscal 2013.
- Achieve Life Sciences, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2013 was $63.38M, a 22.88% decline from fiscal 2012.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 12 month |
|---|---|---|---|---|
| 2017-06-30 | $759.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $10.23M 10-Q · filed 2017-07-31 | $23.03M derived: sum of 3 quarters · filed 2017-07-31 | $36.53M derived: sum of 4 quarters · filed 2017-07-31 |
| 2017-03-31 | $9.47M 10-Q · filed 2017-05-15 | $22.27M derived: sum of 2 quarters · filed 2017-05-15 | $35.77M derived: sum of 3 quarters · filed 2017-05-15 | $38.77M derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-12-31 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $26.30M derived: sum of 2 quarters · filed 2017-02-23 | $29.30M derived: sum of 3 quarters · filed 2017-07-31 | $47.16M 10-K · filed 2017-02-23 |
| 2016-09-30 | $13.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $16.50M derived: sum of 2 quarters · filed 2017-07-31 | $34.36M 10-Q · filed 2016-11-10 | $38.36M derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $20.86M 10-Q · filed 2017-07-31 | $24.86M derived: sum of 3 quarters · filed 2017-07-31 | $34.51M derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-03-31 | $17.86M 10-Q · filed 2017-05-15 | $21.86M derived: sum of 2 quarters · filed 2017-05-15 | $31.51M derived: sum of 3 quarters · filed 2017-05-15 | $36.51M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $13.65M derived: sum of 2 quarters · filed 2017-02-23 | $18.65M derived: sum of 3 quarters · filed 2017-02-23 | $21.66M 10-K · filed 2017-02-23 |
| 2015-09-30 | $9.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $14.65M derived: sum of 2 quarters · filed 2016-11-10 | $17.66M 10-Q · filed 2016-11-10 | $17.71M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $8.01M 10-Q · filed 2016-08-04 | $8.06M derived: sum of 3 quarters · filed 2017-02-23 | $8.06M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $3.01M 10-Q · filed 2016-05-12 | $3.06M derived: sum of 2 quarters · filed 2017-02-23 | $3.06M derived: sum of 3 quarters · filed 2017-02-23 | $12.15M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $49.00K derived: sum of 2 quarters · filed 2017-02-23 | $9.14M derived: sum of 3 quarters · filed 2017-02-23 | $24.89M 10-K · filed 2017-02-23 |
| 2014-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $9.09M derived: sum of 2 quarters · filed 2015-11-12 | $24.85M 10-Q · filed 2015-11-12 | $33.13M derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-06-30 | $9.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $24.84M 10-Q · filed 2015-08-13 | $33.12M derived: sum of 3 quarters · filed 2016-03-09 | $39.09M derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-03-31 | $15.76M 10-Q · filed 2015-05-14 | $24.04M derived: sum of 2 quarters · filed 2016-03-09 | $30.00M derived: sum of 3 quarters · filed 2016-03-09 | $59.51M derived: sum of 4 quarters · filed 2016-03-09 |
| 2013-12-31 | $8.28M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $14.24M derived: sum of 2 quarters · filed 2016-03-09 | $43.75M derived: sum of 3 quarters · filed 2016-03-09 | $63.38M 10-K · filed 2016-03-09 |
| 2013-09-30 | $5.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $35.47M derived: sum of 2 quarters · filed 2014-10-30 | $55.10M 10-Q · filed 2014-10-30 | $90.27M derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-06-30 | $29.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $49.13M 10-Q · filed 2014-08-07 | $84.30M derived: sum of 3 quarters · filed 2015-03-26 | |
| 2013-03-31 | $19.63M 10-Q · filed 2014-04-30 | $54.80M derived: sum of 2 quarters · filed 2015-03-26 | ||
| 2012-12-31 | $35.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $82.18M 10-K · filed 2015-03-26 | ||
| 2012-09-30 | $47.01M 10-Q · filed 2013-11-07 | |||
| 2011-12-31 | $87.64M 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |